B

비피도

238200KOSDAQ

56.4 / 100

Reference Date: 2026-09-08

Financial Score21.5 / 40
News Sentiment16.9 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 3.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Bifido is a company that produces probiotic raw materials and finished products based on physiologically active bifidobacteria strains discovered by Professor Ji Geun-eok in 1994. It holds FDA NDI and GRAS certifications and utilizes the MAP platform technology to develop functional probiotics and microbiome-based therapeutics. The company is also expanding into B2C markets through the development of individually recognized probiotic raw materials.

Number of Employees

102people

Average Salary

42.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
0.48Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-0.42Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
1.00Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲12.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼537.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -3.1% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 1Negative 0Average Sentiment Score 67.5

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 2,675Won52-week high 4,33552-week low 2,215
1-month return4.0Point

1m +3.08% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral합병등종료보고서(자산양수도)2026-08-14
  • Neutral반기보고서 (2026.06)2026-08-14